Lazard Asset Management LLC Cytosorbents Corp Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.86 - $1.07 $130 - $162	152 Added 16.2%	1,090 $1,000
Q4 2023 Feb 14, 2024	BUY	$1.08 - $1.94 $1,013 - $1,819	938 New	938 $1,000
Q4 2021 Feb 09, 2022	SELL	$4.05 - $8.11 $21,752 - $43,558	-5,371 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.0 - $9.71 $30,513 - $42,325	4,359 Added 430.73%	5,371 $43,000
Q2 2021 Aug 12, 2021	SELL	$7.55 - $9.42 $28,818 - $35,956	-3,817 Reduced 79.04%	1,012 $7,000
Q4 2020 Feb 11, 2021	BUY	$7.65 - $8.98 $36,941 - $43,364	4,829 New	4,829 $38,000

16.7M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $42.3M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.